Cargando…
MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2
Hepatocellular carcinoma (HCC) is one of the most widespread malignant human tumors worldwide. Treatment options include radiotherapy, surgical intervention and chemotherapy; however, drug resistance is an ongoing treatment concern. In the present study, the effects of a microRNA (miR/miRNA), miR-9,...
Autores principales: | Xue, Fei, Liang, Yuntian, Li, Zhenrong, Liu, Yanhui, Zhang, Hongwei, Wen, Yu, Yan, Lei, Tang, Qiang, Xiao, Erhui, Zhang, Dongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772877/ https://www.ncbi.nlm.nih.gov/pubmed/29399149 http://dx.doi.org/10.3892/ol.2017.7399 |
Ejemplares similares
-
Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression
por: Xue, Fei, et al.
Publicado: (2016) -
MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2
por: Tu, Chaoyong, et al.
Publicado: (2019) -
Eukaryotic translation initiation factor 5A in the pathogenesis of cancers
por: Ning, Liang, et al.
Publicado: (2020) -
USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
por: Li, Zengxia, et al.
Publicado: (2018) -
MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)